Jesse Shefferman - Net Worth and Insider Trading

Jesse Shefferman Net Worth

The estimated net worth of Jesse Shefferman is at least $1 Million dollars as of 2023-09-30. Jesse Shefferman is the CEO and President of Protara Therapeutics Inc and owns about 879,441 shares of Protara Therapeutics Inc (TARA) stock worth over $1 Million. Details can be seen in Jesse Shefferman's Latest Holdings Summary section.

Transaction Summary of Jesse Shefferman


Jesse Shefferman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jesse Shefferman owns 1 companies in total, including Protara Therapeutics Inc (TARA) .

Click here to see the complete history of Jesse Shefferman’s form 4 insider trades.

Insider Ownership Summary of Jesse Shefferman

Ticker Comapny Transaction Date Type of Owner
TARA Protara Therapeutics Inc 2020-01-09 director & CEO and President

Jesse Shefferman Latest Holdings Summary

Jesse Shefferman currently owns a total of 1 stock. Jesse Shefferman owns 879,441 shares of Protara Therapeutics Inc (TARA) as of August 11, 2022, with a value of $1 Million.

Latest Holdings of Jesse Shefferman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TARA Protara Therapeutics Inc 2022-08-11 879,441 1.67 1,468,666

Holding Weightings of Jesse Shefferman

Jesse Shefferman Form 4 Trading Tracker

According to the SEC Form 4 filings, Jesse Shefferman has made a total of 1 transactions in Protara Therapeutics Inc (TARA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Protara Therapeutics Inc is the acquisition of 9,065 shares on August 11, 2022, which cost Jesse Shefferman around $34,810.

Insider Trading History of Jesse Shefferman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jesse Shefferman Trading Performance

GuruFocus tracks the stock performance after each of Jesse Shefferman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jesse Shefferman is -24.68%. GuruFocus also compares Jesse Shefferman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jesse Shefferman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jesse Shefferman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jesse Shefferman

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 10.25 -24.68 -4.76 -31.89
Relative Return to S&P 500(%) 13.58 -19.59 -1.98 -37.99

Jesse Shefferman Ownership Network

Ownership Network List of Jesse Shefferman

No Data

Ownership Network Relation of Jesse Shefferman

Jesse Shefferman Owned Company Details

What does Protara Therapeutics Inc do?

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Who are the key executives at Protara Therapeutics Inc?

Jesse Shefferman is the director & CEO and President of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include Chief Financial Officer Patrick Fabbio , VP & Controller Hannah Fry , and Chief Medical Officer Jathin Bandari .

Protara Therapeutics Inc (TARA) Insider Trades Summary

Over the past 18 months, Jesse Shefferman made 1 insider transaction in Protara Therapeutics Inc (TARA) with a net purchase of 9,065. Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net purchase of 28,699 shares made by Opaleye Management Inc. , a net purchase of 10,000 shares made by Luke M Beshar ,

In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,473 shares of Protara Therapeutics Inc (TARA) were sold and 63,237 shares were bought by its insiders, resulting in a net purchase of 47,764 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.


Protara Therapeutics Inc Insider Transactions

No Available Data

Jesse Shefferman Mailing Address

Above is the net worth, insider trading, and ownership report for Jesse Shefferman. You might contact Jesse Shefferman via mailing address: C/o Artara Therapeutics,inc., 1 Little West 12th Street, New York Ny 10014.

Discussions on Jesse Shefferman

No discussions yet.